Neonatal adrenal function after repeat dose prenatal corticosteroids: a randomized controlled trial

Am J Obstet Gynecol. 2006 Mar;194(3):861-7. doi: 10.1016/j.ajog.2005.08.063.

Abstract

Objective: Do repeat prenatal corticosteroids suppress neonatal cortisol concentrations?

Study design: Randomized controlled trial of women given weekly repeat corticosteroids or saline placebo, while at risk of preterm birth, until 32 weeks' gestation.

Results: Cord serum cortisol concentrations in infants exposed to repeat corticosteroids were similar compared with infants exposed to a single course of corticosteroids (mean difference -26 nmol/L (95% CI -57, 5 nmol/L, P = .10), as were prestress salivary cortisol concentrations on day 3 (median 16.5 vs 15.3 nmol/L, P = .96). The adrenal response to a stressor on day 3 was lower in the repeat corticosteroid group compared with the single course group (median 11.9 vs 21.4 nmol/L, P = .02). Cortisol concentrations were lower in the repeat corticosteroid group on day 7 (median 11.7 vs 18.2 nmol/L, P = .04), but not on days 14 and 21.

Conclusion: The short- or long-term clinical impact, if any, of these changes in adrenal function needs to be determined.

Publication types

  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adrenal Glands / drug effects
  • Adrenal Glands / physiology*
  • Adult
  • Betamethasone / administration & dosage
  • Betamethasone / analogs & derivatives*
  • Betamethasone / pharmacology
  • Female
  • Fetal Blood / chemistry
  • Glucocorticoids / administration & dosage*
  • Glucocorticoids / pharmacology
  • Humans
  • Hydrocortisone / analysis*
  • Hydrocortisone / blood
  • Infant, Newborn
  • Pregnancy
  • Prenatal Care*
  • Saliva / chemistry

Substances

  • Glucocorticoids
  • betamethasone acetate phosphate
  • Betamethasone
  • Hydrocortisone